Models of Hepatitis C Care for People with Substance Use Disorders: Creating Treatment Champions

AETC National Coordinating Resource Center Graphic Identity

This webinar will focus on strategies to increase access to hepatitis C virus (HCV) treatment for people with substance use disorders. The overall goal is to encourage more providers to integrate HCV care into their practice for both HCV mono- and HIV/HCV co-infected clients. 

Learning objectives:

  • Understand and address common misconceptions about providing HCV treatment to people with substance use disorders.
  • Discuss the role of clinical champions in improving access to HCV treatment for people with substance use disorders.  
  • Describe emerging models of care for engaging people with substance use disorders in HCV treatment and support. 
  • Describe considerations for special scenarios including HIV or hepatitis B virus (HBV) co-infection, pregnant/parenting women, under/uninsured patients, and unstable housing.  
  • Identify available resources for additional information and clinical support. 


  • Carolyn Chu, MD, MSc, FAAFP, AAHIVS  
    Associate Professor, Department of Family & Community Medicine
    Clinical Director and Associate Director, National Clinician Consultation Center
    University of California San Francisco
  • Philip J. Bolduc, MD, AAHIVS
    Assistant Professor, University of Massachusetts Medical School Department of Family Medicine and Community Health
    Associate Medical Director of Special Populations, Family Health Center of Worcester, Inc.
    Principal Investigator, New England AETC
  • Betty Dong, PharmD, FASHP, FAPHA, FCCP, AAHIVP
    Professor of Clinical Pharmacy
    University of California
    San Francisco School of Pharmacy
  • Marguerite Beiser, ANP-BC, AAHIVS
    Director of HCV Services
    Boston Health Care for the Homeless Program
Target Audience: Clinicians, Public Health Professionals.

Registration required. Contact Liz Lazo at [email protected] if you have any questions.